Sanofi Aventis (Euronext code: SAN, NYSE: SNY) and BMP Sunstone (Nasdaq Stock Code: BJGP) today announced the signing of a formal trade contract.
Sanofi - Aventis will be a cash price of 10 dollars per share,paper napkins BMP Sunstone acquisition of all issued and outstanding shares to calculate diluted shares in the acquisition price of approximately $ 520,600,000. BMP Sunstone with Sanofi - Aventis Group, a wholly owned subsidiary of the merger.
The purchase price per share reached an agreement over BMP Sunstone October 27, 2010 closing price of the final 30% premium.paper tissue BMP Sunstone's Board of Directors has unanimously agreed to approve the transaction.
BMP Sunstone in 2009 sales of approximately 147 million, of which 60% came from health pharmaceutical products. Pharmaceutical products in their health or four-tier cities in China have a strong sales network, mainly through retail outlets, hospitals and community treatment center at the county level to carry out sales. The company has two well-known health medicine brands in China, where "good baby" as the nation's largest pediatric cough and cold brand, and "Women and Sport Special" is a famous brand of feminine hygiene products.
Following the recent establishment of the production of vitamin mineral supplements, a joint venture ---- Hangzhou Sanofi Minsheng Pharmaceutical Co., Ltd. health, the Sanofi - Aventis acquisition initiatives BMP Sunstone will become one of the leading construction group Kang Pharmaceutical Company, and vitamin mineral supplements and cough and cold the two largest segments of the market in a strong position.
Sanofi - Aventis CEO Wei Bahe (ChristopherA.Viehbacher), said: "The acquisition of BMP Sunstone will bring us new distribution channels, boosting the health of Chinese medicine business take off. Chinese medicine market one-third of sales in future years will come from these channels. With this strategic acquisition, Sanofi - Aventis strengthened the overall advantages in the Chinese market and leadership position. "
BMP Sunstone CEO of Upper Primary English, said: "This acquisition will immediately BMP Sunstone to bring significant benefits to shareholders, and employees and customers to create significant value. I am very pleased to work with Sanofi - Aventis team work together to capture the Chinese pharmaceutical market, the growth of health opportunities. "
Under the agreement, the transaction will be the General Assembly agree Dan Gudong BMP sun and domestic regulatory approval and to satisfy the relevant conditions to complete. BMP Sunstone total holding 23% of diluted shares of shareholders have pledged to support the deal.
Health medicine is Sanofi - Aventis the core strategy for sustainable growth platforms. Health of the world's fifth largest pharmaceutical company, Sanofi - Aventis, to grasp the internal and external growth opportunities, and constantly open up the health pharmaceutical market.
China's pharmaceutical market is the health of the world's second largest after the U.S. market, market size in 2010 about 120 million euros. Since 2005, the Chinese pharmaceutical market healthy compound annual growth rate of about 11%. With the continuous deepening of the urbanization process, consumers can continue to improve the ability to pay, the growing trend of self-care, pharmacy and retail chain development and expansion of the rich end products, the domestic health market in the next few years, medicine will continue to maintain good growth momentum.